GBP2、CASP1基因在溃疡性结肠炎和克罗恩病及其护理中的作用
The Role of GBP2 and CASP1 Genes in Ulcerative Colitis and Crohn’s Disease and the Nursing
DOI: 10.12677/acm.2024.1492576, PDF,   
作者: 杜文秀*:中国航天科工集团七三一医院肛肠外科,北京;杜 泓:华北理工大学冀唐学院,河北 唐山
关键词: GBP2CASP1溃疡性结肠炎克罗恩病差异表达基因护理GBP2 CASP1 Ulcerative Colitis Crohn’s Disease Differentially Expressed Genes Nursing
摘要: 背景:溃疡性结肠炎是一种以结肠黏膜的慢性炎症为特征的疾病。克罗恩病是一种炎症性肠道疾病。GBP2、CASP1基因在溃疡性结肠炎和克罗恩病及其护理中的作用尚不清楚。方法:溃疡性结肠炎数据集GSE11223和克罗恩病数据集GSE186582配置文件是从GPL1708、GPL570生成的基因表达综合数据库(GEO)中下载的。进行差异表达基因(DEGs)的筛选,加权基因共表达网络分析(WGCNA),蛋白质–蛋白质相互作用(PPI)网络的构建与分析,功能富集分析,基因集合富集分析(GSEA),免疫浸润分析。绘制基因表达量热图。结果:鉴定出474个DEGs。根据基因本体论(GO)分析,它们主要富集在细胞因子介导的信号通路、细胞内囊泡、细胞表面、信号受体结合。京都基因和基因组百科全书(KEGG)分析结果显示,靶细胞主要富集在趋化因子信号通路、TNF信号通路、IL-17信号通路。WGCNA中的软阈值功率设置为5。获得了7个核心基因(GBP2, GBP1, GBP5, SAMD9L, CASP1, IFITM3, IFITM2)。基因表达量热图发现3个核心基因(GBP5, GBP2, CASP1)在溃疡性结肠炎样本中高表达,在正常组织样本中低表达。对于克罗恩病,GBP5基因在疾病和正常样本中都是低表达,GBP2、CASP1基因高表达。结论:GBP2和CASP1在溃疡性结肠炎和克罗恩病中高表达,可能通过细胞调节等途径在溃疡性结肠炎和克罗恩病的护理中发挥重要作用。
Abstract: Background: Ulcerative colitis is characterized by chronic inflammation of the colon mucosa. Crohn’s disease is an inflammatory bowel disease. The role of GBP2 and CASP1 genes in ulcerative colitis and Crohn’s disease and their care remains unclear. Methods: Ulcerative colitis dataset GSE11223 and Crohn’s disease dataset GSE186582 profiles were downloaded from the Gene Expression Omnibus (GEO) generated from GPL1708, GPL570. Differentially expressed genes (DEGs) were screened, followed by weighted gene co-expression network analysis (WGCNA), construction and analysis of protein-protein interaction (PPI) networks, functional enrichment analysis, gene set enrichment analysis (GSEA), and immune infiltration analysis. Heatmaps of gene expression were plotted. Results: 474 DEGs were identified. According to Gene Ontology (GO) analysis, they were mainly enriched in cytokine-mediated signaling pathways, intracellular vesicles, cell surface, and signal receptor binding. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that the target cells were primarily enriched in chemokine signaling pathways, TNF signaling pathway, and IL-17 signaling pathway. The soft-thresholding power in WGCNA was set to 5. Seven core genes (GBP2, GBP1, GBP5, SAMD9L, CASP1, IFITM3, IFITM2) were obtained. The heatmap of gene expression revealed that three core genes (GBP5, GBP2, CASP1) were highly expressed in ulcerative colitis samples and lowly expressed in normal tissue samples. For Crohn’s disease, the GBP5 gene was lowly expressed in both disease and normal samples, while GBP2 and CASP1 genes were highly expressed. Conclusion: GBP2 and CASP1 are highly expressed in ulcerative colitis and Crohn’s disease, and may play an important role in the care of ulcerative colitis and Crohn’s disease through cellular regulation and other pathways.
文章引用:杜文秀, 杜泓. GBP2、CASP1基因在溃疡性结肠炎和克罗恩病及其护理中的作用[J]. 临床医学进展, 2024, 14(9): 1127-1141. https://doi.org/10.12677/acm.2024.1492576

参考文献

[1] Feuerstein, J.D. and Cheifetz, A.S. (2014) Ulcerative Colitis: Epidemiology, Diagnosis, and Management. Mayo Clinic Proceedings, 89, 1553-1563. [Google Scholar] [CrossRef] [PubMed]
[2] Du, L. and Ha, C. (2020) Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterology Clinics of North America, 49, 643-654. [Google Scholar] [CrossRef] [PubMed]
[3] Gordon, I.O., Abushamma, S., Kurowski, J.A., Holubar, S.D., Kou, L., Lyu, R., et al. (2021) Paediatric Ulcerative Colitis Is a Fibrotic Disease and Is Linked with Chronicity of Inflammation. Journal of Crohns and Colitis, 16, 804-821. [Google Scholar] [CrossRef] [PubMed]
[4] Zhu, M. and Ran, Z. (2021) Clinical Characteristics of Ulcerative Colitis in Elderly Patients. JGH Open, 5, 849-854. [Google Scholar] [CrossRef] [PubMed]
[5] Nakase, H., Sato, N., Mizuno, N. and Ikawa, Y. (2022) The Influence of Cytokines on the Complex Pathology of Ulcerative Colitis. Autoimmunity Reviews, 21, Article 103017. [Google Scholar] [CrossRef] [PubMed]
[6] Aniwan, S., Park, S.H. and Loftus, E.V. (2017) Epidemiology, Natural History, and Risk Stratification of Crohn’s Disease. Gastroenterology Clinics of North America, 46, 463-480. [Google Scholar] [CrossRef] [PubMed]
[7] Torres, J., Mehandru, S., Colombel, J. and Peyrin-Biroulet, L. (2017) Crohn’s Disease. The Lancet, 389, 1741-1755. [Google Scholar] [CrossRef] [PubMed]
[8] Geldof, J., Iqbal, N., LeBlanc, J., Anandabaskaran, S., Sawyer, R., Buskens, C., et al. (2022) Classifying Perianal Fistulising Crohn’s Disease: An Expert Consensus to Guide Decision-Making in Daily Practice and Clinical Trials. The Lancet Gastroenterology & Hepatology, 7, 576-584. [Google Scholar] [CrossRef] [PubMed]
[9] Rieder, F., Zimmermann, E.M., Remzi, F.H. and Sandborn, W.J. (2013) Crohn’s Disease Complicated by Strictures: A Systematic Review. Gut, 62, 1072-1084. [Google Scholar] [CrossRef] [PubMed]
[10] Rangan, P., Choi, I., Wei, M., Navarrete, G., Guen, E., Brandhorst, S., et al. (2019) Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Reports, 26, 2704-2719.E6. [Google Scholar] [CrossRef] [PubMed]
[11] Gauthier, J., Vincent, A.T., Charette, S.J. and Derome, N. (2018) A Brief History of Bioinformatics. Briefings in Bioinformatics, 20, 1981-1996. [Google Scholar] [CrossRef] [PubMed]
[12] Azad, R.K. and Shulaev, V. (2018) Metabolomics Technology and Bioinformatics for Precision Medicine. Briefings in Bioinformatics, 20, 1957-1971. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, Y., Zhao, Y., Bollas, A., Wang, Y. and Au, K.F. (2021) Nanopore Sequencing Technology, Bioinformatics and Applications. Nature Biotechnology, 39, 1348-1365. [Google Scholar] [CrossRef] [PubMed]
[14] Pugliese, D., Felice, C., Papa, A., Gasbarrini, A., Rapaccini, G.L., Guidi, L., et al. (2016) Anti TNF-α Therapy for Ulcerative Colitis: Current Status and Prospects for the Future. Expert Review of Clinical Immunology, 13, 223-233. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, C., Li, W., Wang, H., Ma, Y., Zhao, X., Zhang, X., et al. (2019) Saccharomyces Boulardii Alleviates Ulcerative Colitis Carcinogenesis in Mice by Reducing TNF-α and IL-6 Levels and Functions and by Rebalancing Intestinal Microbiota. BMC Microbiology, 19, Article No. 246. [Google Scholar] [CrossRef] [PubMed]
[16] Anka Idrissi, D., Senhaji, N., Aouiss, A., Khalki, L., Tijani, Y., Zaid, N., et al. (2021) IL-1 and CD40/CD40L Platelet Complex: Elements of Induction of Crohn’s Disease and New Therapeutic Targets. Archives of Pharmacal Research, 44, 117-132. [Google Scholar] [CrossRef] [PubMed]
[17] Peters, V.A., Joesting, J.J. and Freund, G.G. (2013) IL-1 Receptor 2 (IL-1R2) and Its Role in Immune Regulation. Brain, Behavior, and Immunity, 32, 1-8. [Google Scholar] [CrossRef] [PubMed]
[18] Li, M., Luo, H., Wu, X., Liu, Y., Gan, Y., Xu, N., et al. (2020) Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Frontiers in Pharmacology, 10, Article 1552. [Google Scholar] [CrossRef] [PubMed]
[19] Qu, Y., Li, X., Xu, F., Zhao, S., Wu, X., Wang, Y., et al. (2021) Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis. Frontiers in Immunology, 12, Article 679897. [Google Scholar] [CrossRef] [PubMed]
[20] Wei, Y., Fan, Y., Ga, Y., Zhang, Y., Han, J. and Hao, Z. (2021) Shaoyao Decoction Attenuates DSS-Induced Ulcerative Colitis, Macrophage and NLRP3 Inflammasome Activation through the MKP1/NF-κB Pathway. Phytomedicine, 92, Article 153743. [Google Scholar] [CrossRef] [PubMed]
[21] Henckaerts, L. and Vermeire, S. (2007) NOD2/CARD15 Disease Associations Other than Crohnʼs Disease. Inflammatory Bowel Diseases, 13, 235-241. [Google Scholar] [CrossRef] [PubMed]
[22] Siddique, I., Mustafa, A., Khan, I., Ziyab, A., Altarrah, M., Sulaiman, R., et al. (2021) Detection of Mutations in NOD2/ CARD15 Gene in Arab Patients with Crohn’s Disease. Saudi Journal of Gastroenterology, 27, 240-248. [Google Scholar] [CrossRef] [PubMed]
[23] Naser, S.A. (2012) Role of ATG16L, NOD2 and IL23R in Crohn’s Disease Pathogenesis. World Journal of Gastroenterology, 18, 412-424. [Google Scholar] [CrossRef] [PubMed]
[24] Radford-Smith, G. (2006) Associations between NOD2/CARD15 Genotype and Phenotype in Crohn’s Disease-Are We There Yet. World Journal of Gastroenterology, 12, 7097. [Google Scholar] [CrossRef] [PubMed]
[25] Chiba, T., Endo, M., Miura, S., Hayashi, Y., Asakura, Y., Oyama, K., et al. (2019) Regulatory T Cells in Crohn’s Disease Following Anti‐TNF‐α Therapy. JGH Open, 4, 378-381. [Google Scholar] [CrossRef] [PubMed]
[26] Yamamoto, T., Teixeira, F.V., Saad-Hossne, R., Kotze, P.G. and Danese, S. (2019) Anti-TNF and Postoperative Complications in Abdominal Crohn’s Disease Surgery. Current Drug Targets, 20, 1339-1348. [Google Scholar] [CrossRef] [PubMed]
[27] D’Haens, G.R. and van Deventer, S. (2021) 25 Years of Anti-TNF Treatment for Inflammatory Bowel Disease: Lessons from the Past and a Look to the Future. Gut, 70, 1396-1405. [Google Scholar] [CrossRef] [PubMed]
[28] Poornima, G., Srivastava, G., Roy, B., Kuttanda, I.A., Kurbah, I. and Rajyaguru, P.I. (2021) RGG-Motif Containing mRNA Export Factor Gbp2 Acts as a Translation Repressor. RNA Biology, 18, 2342-2353. [Google Scholar] [CrossRef] [PubMed]
[29] Windgassen, M. and Krebber, H. (2003) Identification of Gbp2 as a Novel Poly(A)+ RNA‐Binding Protein Involved in the Cytoplasmic Delivery of Messenger RNAs in Yeast. EMBO Reports, 4, 278-283. [Google Scholar] [CrossRef] [PubMed]
[30] Kapplusch, F., Schulze, F., Rabe-Matschewsky, S., Russ, S., Herbig, M., Heymann, M.C., et al. (2019) CASP1 Variants Influence Subcellular Caspase-1 Localization, Pyroptosome Formation, Pro-Inflammatory Cell Death and Macrophage Deformability. Clinical Immunology, 208, Article 108232. [Google Scholar] [CrossRef] [PubMed]
[31] (2015) The NLRP3-CASP1 Inflammasome Induces Glucocorticoid Resistance in ALL. Cancer Discovery, 5, OF18. [Google Scholar] [CrossRef
[32] Wang, H., Zhou, Y., Zhang, Y., Fang, S., Zhang, M., Li, H., et al. (2022) Subtyping of Microsatellite Stability Colorectal Cancer Reveals Guanylate Binding Protein 2 (GBP2) as a Potential Immunotherapeutic Target. Journal for ImmunoTherapy of Cancer, 10, e004302. [Google Scholar] [CrossRef] [PubMed]
[33] Cerretti, D.P., Hollingsworth, L.T., Kozlosky, C.J., Valentine, M.B., Shapiro, D.N., Morris, S.W., et al. (1994) Molecular Characterization of the Gene for Human Interleukin-1β Converting Enzyme (IL1BC). Genomics, 20, 468-473. [Google Scholar] [CrossRef] [PubMed]